Synaptogenix Inc (SNPX)

[dia76ca]

"We have to prove it again." I agree. This is true for both companies.

NTRP has the expertise of Dr Alkon. Anavex has the expertise of Dr. Hampel. I agree. Both companies have world class expertise.

Both companies have drugs which are safe in the short run. Both need longer term safety data. Both need to demonstrate both short and long term efficacy.Both require double blinded, placebo controlled clinical evidence.

Both companies have an entire platform of drugs. Both will need further funding to bring these platforms into the clinic.

Both companies will have significant data around the middle of next year.(NTRP in late stage Alzheimer's:AVXL in Parkinson's and Rett) If the data is good I expect both will partner next year.

The companies Alzheimer's trials do differ in that one is targeting late stage Alzheimer's and the other is targeting early stage Alzheimer's.

I hope both are successful. Indeed I hope there may be a synergy between the two drugs. Combination therapy is the wave of the future in most health care areas.